The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shchukina N.A.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kareva E.N.

N.I. Pirogov Russian National Research Medical University

Kochetkova A.A.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Babunashvili E.L.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Glebov T.A.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kotsuba D.R.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Controversial issues of adjuvant therapy after myomectomy

Authors:

Shchukina N.A., Kareva E.N., Kochetkova A.A., Babunashvili E.L., Glebov T.A., Kotsuba D.R.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2024;24(5): 101‑107

DOI: 10.17116/rosakush202424051101

Read: 1289 times

Download PDF (RU)
Contact the author
Table of contents

CONTROVERSIAL ISSUES OF ADJUVANT THERAPY AFTER MYOMECTOMY
CONTROVERSIAL ISSUES OF ADJUVANT THERAPY AFTER MYOMECTOMY

To cite this article:

Shchukina NA, Kareva EN, Kochetkova AA, Babunashvili EL, Glebov TA, Kotsuba DR. Controversial issues of adjuvant therapy after myomectomy. Russian Bulletin of Obstetrician-Gynecologist. 2024;24(5):101‑107. (In Russ.)
https://doi.org/10.17116/rosakush202424051101

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Comparative analysis of the effe­ctiveness of therapy for endo­metrial hype­rplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):75-83
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
Morpho-functional features of the endo­metrium in uterine leiomyoma before and after embo­lization of the uterine arte­ries. Russian Journal of Archive of Pathology. 2025;(4):13-23
Abstract:

Uterine fibroids are one of the most common tumors of the female reproductive system. In this article, based on the latest domestic and world publications and clinical recommendations of the Russian Federation, the issues of adjuvant therapy in patients with uterine fibroids after myomectomy (the use of GnRH agonists-antagonist and selective progesterone receptor modulators — SPRM) are highlighted.

Keywords:

uterine fibroids
adjuvant therapy after myomectomy
GnRH
SPRM

Authors:

Shchukina N.A.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kareva E.N.

N.I. Pirogov Russian National Research Medical University

Kochetkova A.A.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Babunashvili E.L.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Glebov T.A.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kotsuba D.R.

V.I. Krasnopolskyi Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Received:

30.08.2024

Accepted:

04.09.2024

Close metadata

References:

  1. Revazova Z.V., Adamyan L.V., Arslanyan K.N., Loginova O.N., Kozachenko A.V., Demura T.A. Results of surgery after medicine pre-treatment patients with uterine fibroids and heavy menstrual bleeding. Russian Journal of Human Reproduction. 2021;27:1:59-66. (In Russ.). https://doi.org/10.17116/repro20212701159
  2. Revazova Z.V., Manukyan L.M., Arslanyan K.N., Loginova O.N. Modern tactics of preoperative preparation of patients before laparoscopic myomectomy. Colloquium-journal. 2019;3:51:59-63. (In Russ.).
  3. Adamyan L.V., Sonova M.M., Shamugia N.M., Arslanyan K.N., Loginova O.N. New possibilities for treating uterine fibroids in the clinic of operative gynecology. Akusherstvo i ginekologiya: Novosti. Mneniya. Obucheniya. 2015;4:10:30-35. (In Russ.).
  4. Ferrario L, Garagiola E, Gerardi C, Bellavia G, Colombo S, Ticca C, Rossetti C, Ciboldi M, Meroni M, Vanzulli A, Rampoldi A, Bignardi T, Arrigoni F, Porazzi E, Foglia E. Innovative and conventional “conservative” technologies for the treatment of uterine fibroids in Italy: a multidimensional assessment. Health Econ Rev. 2022;12:1:21. 
  5. American College of Obstetricians and Gynecologists. Management of symptomatic uterine leiomyomas: ACOG practice bulletin, number 228. Obstet Gynecol. 2021;137:e100-15. 
  6. Zatsepin A.V., Novikova V.A., Vasina I.B. Comparison of the effectiveness of pharmacological methods of anti-recurrent treatment of uterine fibroids after conservative myomectomy. Kubanskii nauchnyi meditsinskii vestnik. 2012;131:2:88-92. (In Russ.).
  7. Babunashvili E.L., Shchukina N.A., Buyanova S.N., Budykina T.S., Tikhomirova E.V., Glebov T.A., Son D.Yu., Kotsuba D.R. Possibilities of rehabilitation of patients of reproductive age after myomectomy. Russian Bulletin of Obstetrician-Gynecologist. 2022;22:3:93-99. (In Russ.). https://doi.org/10.17116/rosakush20222203193
  8. Shchukina N.A., Buyanova S.N., Babunashvili E.L., Zemskova N.Yu., Glebov T.A., Son D.Yu., Kochetkova A.A., Bespalova A.G. Proliferative diseases of the uterus. What to prefer in the postoperative rehabilitation program? Russian Bulletin of Obstetrician-Gynecologist. 2023;23:5:100-105. (In Russ.). https://doi.org/10.17116/rosakush202323051100
  9. Buyanova S.N., Barinova I.V., Voloshchuk I.N., Gukasyan S.A., Yudina N.V., Babunashvili E.L., Glebov T.A., Son D.Yu. Giant uterine myoma in a patient with congenital adrenal cortex dysfunction. Russian Bulletin of Obstetrician-Gynecologist. 2021;21:6:73-76. (In Russ.). https://doi.org/10.17116/rosakush20212106173
  10. Sidorova I.S., Kogan E.A., Unanyan A.L., Kiselev V.I., Ageev M.B. Clinical and morphological correlations for different types of uterine myoma growth. Russian Bulletin of Obstetrician-Gynecologist. 2019;19:3:29-36. (In Russ.). https://doi.org/10.17116/rosakush20191903129
  11. Shchukina N.A., Sheina E.N., Barinova I.V. The clinical and morphological features of uterine myoma in young women. Russian Bulletin of Obstetrician-Gynecologist. 2014;14:5:28-31. (In Russ.).
  12. Tskhai V.B., Badmaeva S.Zh., Narkevich A.N., Tskhai I.I., Mikhailova A.V. A predictive model for calculating the likelihood of recurrent uterine fibroids after surgical intervention. Fundamental’naya i klinicheskaya meditsina. 2021;6:3:64-70. (In Russ.).
  13. Radosa MP, Owsianowski Z, Mothes A, Weisheit A, Vorwergk J, Asskaryar FA, Camara O, Bernardi TS, Runnebaum IB. Long-term risk of fibroid recurrence after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2014;180:35-39. 
  14. Maghi Hanafi, MD Predictors of leiomyoma recurrence after myomectomy. The American College of Obstetricians and Gynecologists. Published by Lippincott. 2005;105:4:877-888. 
  15. Clinical recommendations «Uterine fibroids». Approved by the Ministry of Health of the Russian Federation. Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. Date of approval: 2020. Developer: LLC «Russian Society of Obstetricians and Gynecologists» (ROAG). (In Russ.).
  16. Buyanova S.N., Logutova L.S., Shchukina N.A., Mgeliashvili M.V., Yudina N.V., Gukasyan S.A., Akhvlediani K.N., Chechneva M.A., Ermolaeva E.E. Myomectomy in pregnancy and non-pregnancy: indications, the specific features of surgical policy and anesthesia, and preoperative preparation and rehabilitation. Russian Bulletin of Obstetrician-Gynecologist. 2013;13:2:95-100. (In Russ.).
  17. Buyanova S.N., Shchukina N.A., Chechneva M.A., Babunashvili E.L., Yudina N.V., Gukasyan S.A. Atypical uterine myoma in young women: diagnostics, treatment, rehabilitation. Russian Bulletin of Obstetrician-Gynecologist. 2019;19:6:77-83. (In Russ.). https://doi.org/10.17116/rosakush20191906177
  18. Operative gynecology. Krasnopol’skii V.I., Buyanova S.N., Shchukina N.A., Popov A.A. 2nd ed., revised. Moscow: MEDpress-inform. 2018;320. (In Russ.).
  19. Basos A.S., Shkarupa I.A., Shapovalova E.A., Blazhenko A.A. Method of surgical treatment of uterine fibroids in women of reproductive age. Patent 2750911C1 Russian. Federation No. 2020139473; appl. 11/30/2020; publ. 07/06/2021. Bull. No. 19:13. (In Russ.).
  20. Zhang SJ, Guo LS, Deng PZ, Dai SR, Ren QZ, Tao XM, Zhu WP. Application of transvaginal morcellation within disposable extraction bag with traction wire in laparoscopic myomectomy. Zhonghua Yi Xue Za Zhi. 2022;102:26:2030-2032.
  21. Anupama R, Ahmad SZ, Kuriakose S, Vijaykumar DK, Pavithran K, Seethalekshmy NV. Disseminated peritoneal leiomyosarcomas after laparoscopic “myomectomy” and morcellation. J Minim Invasive Gynecol. 2011;18:3:386-389. 
  22. Totchiev G.F., Devyatova E.A. Uterine fibroids: modern methods of treatment. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie. 2016;1:18-24. (In Russ.).
  23. Shchukina N.A., Buyanova S.N., Kondrikov N.I., Tikhomirova A.S., Barinova I.V., Sheina E.N. Uterine leiomyoma in young women: Clinical and morphological aspects. Russian Bulletin of Obstetrician-Gynecologist. 2016;16:1:21-27. (In Russ.). https://doi.org/10.17116/rosakush201616121-27
  24. Shramko S.V., Gulyaeva L.F., Bazhenova L.G., Levchenko V.G. Uterine fibroids and adenomyosis: molecular characterization of steroid receptor gene expression. Akusherstvo i ginekologiya. 2018;4:58-63. (In Russ.).
  25. dos Anjos LG, da Cunha IW, Baracat EC, Carvalho KC. Genetic and Epigenetic Features in uterine smooth muscle tumors: An Update. Clin Oncol. 2019;4:1637.
  26. Radzinskii V.E., Arkhipova M.P. Uterine fibroids: problems and prospects at the turn of the century. Meditsinskii sovet. 2014;9:30-33. (In Russ.).
  27. Krasnopol’skii V.I., Sergeev P.V., Gasparyan N.D., Kareva E.N., Logutova L.S., Buyanova S.N., Titchenko L.I., Babunashvili E.L., Gorbunova T.N. Pregnancy and progesterone-dependent uterine fibroids. Russian Bulletin of Obstetrician-Gynecologist. 2003;3:3:55-57. (In Russ.).
  28. Kareva E.N. Mifepristone and uterine fibroids. Pharmateka. 2010;14:18-30. (In Russ.).
  29. Kareva E.N., Serebrova S.Yu., Kochina N.A., Kononova I.N., Oleinikova O.M., Tikhonov D.A. Selective modulators of progesterone receptors (literature review). Eksperimental’naya i klinicheskaya farmakologiya. 2018;81:10:36-44. (In Russ.).
  30. Kareva E.N., Samoilova T.E. Uterine myoma: new and perspective options for medicinal treatment. Meditsinskii sovet. 2020;3:49-58. (In Russ.).
  31. Steroid hormone receptors in human tumors. Ed. L.S. Bassalyk. Moscow: Medicine. 1987;220. (In Russ.).
  32. Sergeev P.V., Shimanovskii N.L. Receptors of physiologically active substances. Moscow: Medicine. 1987;560. (In Russ.).
  33. Kareva E.N., Bulgakova V.A., Gutorova D.S., Oleinikova O.M., Kononova I.N., Gorbunov A.A., Breusenko V.G., Fisenko V.P. Progesterone membrane receptor PGRMC1: potential drug target. Eksperimental’naya i klinicheskaya meditsina. 2020;83:6:19-29. (In Russ.).
  34. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;2:CD000547. https://doi.org/10.1002/14651858.CD000547
  35. Schindler AE. Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview. Gynecol Endocrinol. 2004;19:1:51-55. 
  36. Sulaiman H, Dawson L, Laurent GJ, Bellingan GJ, Herrick SE. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans. 2002;30:2:126-131. 
  37. Agarwal S.K. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications. J Reprod Med. 1998;43:293-298. 
  38. Chabbert-Buffet N, Esber N, Bouchard P. Fibroid growth and medical options for treatment. Fertil Steril. 2014;102:3:630-639. 
  39. Smith SK. The regulation of fibroid growth: time for a re-think? Br J Obstet Gynaecol. 1993;100:11:977-978. 
  40. Radzinskii V.E., Ordiyants I.M., Khorol’skii V.A. Comparative effectiveness of two regimens for the use of gynestril in the treatment of uterine fibroids. Kubanskii nauchnyi meditsinskii vestink. 2017;24:4:115-121. (In Russ.).
  41. Tapil’skaya N.I., Dukhanin A.S., Glushakov R.I. Influence of drug treatment of symptomatic uterine leiomyoma on the quality of life of women. Russian Journal of Human Reproduction. 2018;24:4:81-88. (In Russ.). https://doi.org/10.17116/repro20182404181
  42. Samoilova T.E. Drug treatment of uterine leiomyoma with antigestagens: possibilities and prospects. Gynekologiya. 2011;13:3:12-18. (In Russ.).
  43. Samoilova T.E., Maksutova D.Zh. Options and prospects for drug treatment of uterine fibroids. Meditsinskii sovet. 2013;3:106-109. (In Russ.).
  44. Apresyan S.V., Dimitrova V.I., Slyusareva O.A. Possibilities of mifepristone use after surgical therapy of uterine myoma. Meditsinskii sovet. 2016;12:142-145. (In Russ.).
  45. Buyanova S.N., Shchukina N.A., Babunashvili E.L. Current medical treatments in patients with uterine myoma, the value of stem cells in the pathophysiology of uterine myoma, and a prospect in the development of new bioengineering techniques for uterine tissue reconstruction. Russian Bulletin of Obstetrician-Gynecologist. 2018;18:4:27-34. (In Russ.). https://doi.org/10.17116/rosakush201818427
  46. Strizhakov A.N., Davydov A.I., Pashkov V.M., Lebedev V.A. Benign diseases of the uterus. A guide for doctors. DataLife Engine DL E-News.RU. 2011;69-72. (In Russ.).
  47. Pregravid preparation. Clinical protocol of the Interdisciplinary Association of Reproductive Medicine Specialists (MARS). M.: Editorial board of the magazine Status Praesens. 2020:128. (In Russ.).
  48. Levakov S.A., Budanov P.V., Zairat’yants O.V., Molvtaeva Kh.R., Azadova G.Ya., Levakova S.E. Personalized approach to the management of patients with uterine fibroids. Akusherstvo i gkinekologiya. 2019;12:174-182. (In Russ.).
  49. Tikhomirov A.L., Dedy T.V., Sarsaniya S.I., Sonina T.A., Kazenashev V.V., Osetskaya E.A. Current strategy for the management of patients with uterine fibroids in an outpatient setting. Trudnyi patsient. 2021;19:4:12-17. (In Russ.).
  50. Clinical recommendations «Hyperplasia of the endometrium». Approved by the Ministry of Health of the Russian Federation. Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. Date of approval: 2021. Developer: LLC «Russian Society of Obstetricians and Gynecologists» (ROAG). (In Russ.).
  51. Shchukina N.A., Buyanova S.N., Babunashvili E.L., Tikhomirova E.V., Zemskova N.Yu., Glebov T.A. Current approaches to drug therapy in patients with concomitant proliferative uterine diseases. Russian Bulletin of Obstetrician-Gynecologist. 2022;22:6:102-108. (In Russ.). https://doi.org/10.17116/rosakush202222061102
  52. Clinical recommendations «Endometriosis». Approved by the ministry of health of the Russian Federation. Approved by the Scientific and Practical Council of the Ministry of health of the Russian Federation. Date of approval: 2020. Developer: LLC «Russian Society of Obstetricians and Gynecologists» (ROAG). (In Russ.).
  53. Tikhomirova E.V., Balan V.E., Kruchinina E.V., Lovygina T.V., Kapitanova O.V., Titchenko Yu.P. Conservative treatment options in patients with combined proliferative uterine disorders. Russian Bulletin of Obstetrician-Gynecologist. 2021;21:5:102-108. (In Russ.). https://doi.org/10.17116/rosakush202121051102
  54. Lapina I.A., Nasyrova N.I. Optimization of the treatment of patients with proliferative diseases of the uterus. Gynekologiya. 2015;17:4:27-31. (In Russ.).
  55. Tikhomirov A.L., Manukhin I.B., Sarsaniya S.I. Uterine myoma concurrent with endometriosis and endometrial hyperplasia. How to treat? Russian Bulletin of Obstetrician-Gynecologist. 2014;14:3:76-78. (In Russ.).
  56. Fedorov A.A., Sopova Yu.I., Popov A.A., Efremova E.S., Bespalova A.G., Buyanova S.N., Yudina N.V. The effect of myomectomy on reproductive outcomes. Russian Bulletin of Obstetrician-Gynecologist. 2020;20:4:47-51. (In Russ.).
  57. Morris JM, Liang A, Fleckenstein K, Singh B, Segars J. A Systematic review of minimally invasive approaches to uterine fibroid treatment for improving quality of life and fibroid-associated symptoms. Reprod Sci. 2023;30:5:1495-1505.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.